SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Beyond Meat, Inc. engages in the provision of plant-based meats. Its products include ready-to-cook meat under The Beyond Burger and Beyond Sausage brands, and frozen meat, namely, Beyond Chicken Strips and Beyond Beef Crumbles. The company was founded by Ethan Walden Brown and Brent Taylor in 2009 and is headquartered in El Segundo, CA.

Beyond Meat Inc

BYND is trending as the community discusses a potential short squeeze, pointing to high short interest and significant pre-market volume. Optimism is fueled by the stock's recent surge and anticipation of further gains, with some drawing comparisons to previous meme stock events like GME. Traders are closely watching for market open volatility and encouraging each other to hold strong.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to a recent earnings report that triggered mixed reactions; while revenue aligned with expectations, an unexpected Brazilian tax dispute impacted EPS, leading to discussions about the company's valuation and future growth prospects. Some investors are weighing potential bounce scenarios and long-term value, while others express concerns about content strategy and broader market conditions. The community is also debating the impact of factors like competition and consumer spending on Netflix's trajectory.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recently announced $5 million production order for its 800G optical engines, signaling a significant step towards commercialization and revenue generation. The community is excited about the potential for more orders and the company's role in the growing optical interconnect market, particularly with possible connections to Meta through Luxshare. Investors are also discussing technical analysis and potential price movements.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending due to the recent announcement of a $5 billion, 15-year AI factory lease with a U.S.-based hyperscaler, expanding its total leased capacity to 600 MW. While the identity of the hyperscaler remains undisclosed, the community speculates about potential big-name partners and the long-term implications of this deal. Discussions also focus on the stock's high short interest and its potential for a short squeeze.

1-800-FLOWERS.COM, Inc. engages in the provision of gift design. It operates through the following segments: Consumer Floral and Gifts, BloomNet, Gourmet Foods and Gift Baskets. The Consumer Floral and Gifts segment focuses on the operation of 1-800-Flowers.com, PersonalizationMall, Alice’s Table, and Things Remembered. The BloomNet segment includes memberships, service offerings to florists, and other products. The Gourmet Foods and Gift Baskets segment involves the management of Harry & David, Wolferman’s, Cheryl’s Cookies, The Popcorn Factory, 1-800- Baskets/DesignPac, Shari’s Berries, and Vital Choice. The company was founded by James Francis McCann in 1976 and is headquartered in Jericho, NY.

1-800 Flowers.com Inc. - Ordinary Shares - Class A

FLWS is trending amid renewed short squeeze speculation and high short interest, with some viewing it as the next potential meme stock play. Community members are discussing the possibility of a significant squeeze, drawing comparisons to previous events like GME, and pointing to a potentially low float. Others cite attractive valuation given insider buying, and the holiday gifting season may serve as a catalyst.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp ($UAMY) is trending due to a proposed acquisition of Larvotto Resources, an Australian mining company with significant antimony and gold reserves, which could make UAMY a major player in the antimony market outside of China. The community is excited about the potential deal, viewing it as a strategic move to secure antimony supply and increase market capitalization, especially with a meeting between Trump and the Australian Prime Minister on the horizon. Discussions also involve speculation around government investment and the company's future growth prospects.

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Applied Dna Sciences Inc

Applied DNA Sciences ($BNBX) is trending as it pivots to a BNB-focused digital asset treasury strategy, attracting attention for its potential in the crypto space. The company's recent private placement to fund this new venture is fueling community discussions around its prospects and potential for a short squeeze. Some traders express skepticism, viewing it as another failed biotech cashing in on crypto hype.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

ARCT is experiencing volatility as investors debate its future following recent results. The community is weighing positive data against a significant stock drop, with some viewing it as an overreaction and a buying opportunity, while others express concern and anticipate a potential bounce. Discussions also involve speculation on short positions and potential strategic moves by the company.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending amid discussions around its recent earnings report and future growth potential. While the company beat expectations, some investors are focused on margin pressures related to new product launches and tariffs. The community is weighing the long-term growth prospects against near-term headwinds, with some anticipating a rebound.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv is trending due to strong Q3 2025 earnings, raised 2025 guidance, and a new collaboration with NVIDIA to advance power infrastructure for AI factories, driving positive sentiment. The community is discussing Vertiv's role in AI data center cooling and power solutions, viewing it as a key player in the AI infrastructure buildout. Some are wary of the stock's valuation and short-term volatility, while others see a buying opportunity amidst the growing demand for AI infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025 Taiho Oncology and Cullinan...

BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy? 

BDTX and Cullinan advance next-gen EGFR inhibitors, but silevertinib's potential and valuation tilt momentum toward BDTX.

Shares of Cullinan Therapeutics Inc. fell in after-hours trading despite the company announcing a licensing agreement with Genrix Bio to develop velinotamig, a clinical-stage BCMA-directed bispecific T cell engager, for autoimmune diseases.The stock closed 1.2% higher at $9.07 on Tuesday before slipping 5.7% to $8.55 in after-hours trading.The deal grants Cullinan exclusive global rights, excluding Greater China, to velinotamig across all indications, with a $20 million upfront payment and potential milestone and royalty payments exceeding $692 million.&nbsp;The addition of velinotamig expands Cullinan’s autoimmune pipeline, alongside its CD19-targeting TCE, and is expected to support the company’s cash runway into 2028.Cullinan plans to leverage data from Genrix’s upcoming Phase 1 study in China to accelerate global development.&nbsp;CEO Nadim Ahmed said velinotamig could offer a “precise and potentially disease-modifying approach” by targeting self-reactive plasma cells implicated in certain autoimmune diseases.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.The stock has declined 26.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portrait of a doctor woman on the background of stock charts. | Image source: Getty Images

Cullinan Therapeutics Stock Slides After-Hours Despite $692M Autoimmune Drug Pact With Genrix

Cullinan Therapeutics secured global rights, excluding Greater China, to velinotamig from Genrix Bio, expanding its autoimmune pipeline with a second T cell engager. 

Equity

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20...

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.
read more...

Commit To Purchase Cullinan Oncology At $7.50, Earn 6.2% Annualized Using Options

Investors eyeing a purchase of Cullinan Oncology Inc (CGEM) stock, but tentative about paying the going market price of 17.15/share, might benefit from considering selling puts among the...

Cullinan Oncology (CGEM, $17.03) Aroon Indicator entered a Downtrend on March 28, 2024.

For the last three days, A.I.dvisor has detected that CGEM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Cullinan Oncology (CGEM, $17.74) Aroon Indicator entered a Downtrend on March 27, 2024.

Cullinan Oncology (CGEM, $16.78) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

This indicator may be signaling that CGEM's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Cullinan Oncology (CGEM, $15.5) Aroon Indicator entered a Downtrend on March 19, 2024.

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Therapeutics Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

CGEM
Cullinan Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CGEM News

CGEMCullinan Oncology Inc